Fda Submission Guide

# FDA Submission Guide ## FDA Medical Device Classification and Pathways ### Class I Devices - **510(k) Exempt** - Most Class I devices - **General Controls** apply (21 CFR 820) - **FDA registration** required - **Device listing** mandatory ### Class II Devices - **510(k) Clearance** - Premarket notification - **General + Special Controls** apply - **Predicate device** identification required - **Substantial equivalence** demonstration ### Class III Devices - **PMA (Premarket Approval)** - Full safety and effectiveness review - **IDE (Investigational Device Exemption)** for clinical studies - **Clinical data** typically required - **Post-market surveillance** obligations ### De Novo Classification - **Novel devices** without predicate - **Low to moderate risk** profile - **Creates new device classification** - **Special controls** development ## Submission Pathways and Requirements ### 1. 510(k) Premarket Notification **Traditional 510(k)** - Predicate device comparison - Performance testing documentation - Software documentation (if applicable) - Labeling and indications for use **Special 510(k)** - Modifications to cleared devices - Design controls documentation - Risk analysis of changes - Performance validation **Abbreviated 510(k)** - Guidance document compliance - Recognized standards conformance - Special controls adherence - Reduced documentation requirements ### 2. PMA (Premarket Approval) **Clinical Investigation Requirements** - IDE study protocol approval - GCP compliance documentation - Clinical study reports - Statistical analysis plans **Manufacturing Information** - ISO 13485 QMS compliance - Manufacturing process validation - Facility inspection readiness - Supply chain documentation ### 3. De Novo Classification Request **Risk-based Classification** - Benefit-risk profile analysis - Predicate device absence justification - Special controls recommendations - Clinical evidence strategy ## FDA Submission Process ### Pre-Submission Activities 1. **Q-Sub Meeting** - Pre-submission consultation 2. **Classification determination** confirmation 3. **Predicate device** identification and analysis 4. **Testing strategy** development and validation 5. **FDA guidance** review and compliance assessment ### Submission Preparation 1. **Technical documentation** compilation per FDA format 2. **Quality system** documentation and readiness 3. **Clinical evidence** compilation (if required) 4. **Labeling** and indications for use finalization 5. **eCopy submission** preparation ### FDA Review Process 1. **Administrative review** (15 days for completeness) 2. **Substantive review** (90 days for 510(k), 180 days for PMA) 3. **Additional information** requests and responses 4. **FDA questions** and clarifications 5. **Clearance/approval** or denial decision ## Special Considerations ### Software as Medical Device (SaMD) - **Software documentation** per FDA guidance - **Cybersecurity** considerations and risk management - **Software lifecycle** process documentation - **Change control** procedures ### Combination Products - **OPDP assignment** determination - **Lead center** coordination - **Intercenter agreement** requirements - **Combination product** specific guidance ### HIPAA Compliance - **Protected Health Information** safeguards - **Business associate** agreements - **Risk assessment** and management - **Breach notification** procedures ## Quality System Requirements ### 21 CFR Part 820 (QSR) - **Design controls** (21 CFR 820.30) - **Document controls** (21 CFR 820.40) - **Management responsibility** (21 CFR 820.20) - **Corrective and preventive actions** (21 CFR 820.100) ## Key Performance Metrics - **Review timeline** adherence and predictability - **First-time clearance** rates and success factors - **Additional information** request frequency - **Post-market compliance** effectiveness - **FDA inspection** readiness and outcomes